Envista (NYSE:NVST) announced today that the FDA cleared the Nobel Biocare N1 implant system of instruments, prosthetic components and surgical protocols. The N1 system includes an implant designed for immediate placement and predictable insertion torques, providing a trioval conical connection for the abutment to slide into place. Additionally, the system has an emergence profile designed […]
Nobel Biocare Holdings AG
Align Technology (NSDQ:ALGN) said today it expanded workflow options for its iTero intraoral scanner, now expanded to include digital workflow for Nobel Biocare implants. Customers using San Jose, Calif.-based company’s iTero system can now order Nobel Biocare implant cases through detnal labs, which in turn can order NobelProcera single-unit restorations for their doctors. “Integrating the digital workflow […]
Danaher (NYSE:DHR) subsidiary Nobel Biocare notched a mixed win in the initial determination from the U.S. International Trade Commission in its patent war with a Straumann subsidiary and a Brazilian manufacturer over dental implant technology. Nobel Biocare filed a complaint in October 2014 with the ITC, asking for an investigation of the importation and sale of the Neodent DriveCM dental implant, made […]
Nobel Biocare Holding may be able to settle a class action lawsuit involving 1,000s of dentists for $1.3 million after a federal judge tentatively OK’d the deal.
The class action, headed by Dr. Jason Yamada, includes any U.S. dentists who bought Nobel implant products (except the company’s NobelDirect Groovy device) – more than 2,900 dentists.
The National Venture Capital Assn. is spearheading a drive to get a bill through the U.S. Senate that would make it easier for small companies to raise money by going public.
The "IPO On Ramp" measure would ease the regulatory requirements for IPOs and temporarily reduce the reporting burdens imposed by the Sarbanes-Oxley Act.
Sorin Group (BIT:SRN) managed to raise its bottom line despite flat sales for 2011 by raising its gross margin via restructuring, posting a profit increase of 48.3% for the year.
The Milanese cardiovascular device maker reported profits of $75.2 million (~€58.0 million) on sales of $963.4 million (~€743.4 million), compared with profits of $50.7 million (~€39.1 million) on sales of $966.5 million (~€745.8 million) during 2010.